Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

33 projects found matching your search criteria :

  1. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

  2. Uncovering the Molecular Basis of Carbon and Nitrogen Metabolic Integration via the Glutamate Pathway in Yarrowia lipoly...

    Call: PRELUDIUM 24 , Panel: NZ9

    Principal investigator: Kacper Patryk Szymański

    Uniwersytet Przyrodniczy we Wrocławiu

  3. Determination of the effect of volume regulated anion channels (VRACs) on the neurovascular unit under ischemic conditio...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: prof. Joanna Maria Pera

    Uniwersytet Jagielloński

  4. Role of Astrocytes in Chronic Stress Resilience

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Piotr Marian Michaluk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  5. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while ...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  6. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  7. Quinoxalino-2,3-diones as potent tools for exploration of ionotropic kainate receptors

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Ewa Monika Szymańska

    Uniwersytet Jagielloński, Collegium Medicum

  8. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

  9. The role of nitric oxide-dependent pathways in the procognitive effects of muscarinic and metabotropic glutamate recepto...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  10. Genesis of dendritic spine head protrusion (SHP) formation

    Call: PRELUDIUM 14 , Panel: NZ3

    Principal investigator: Ewa Blanka Bączyńska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  11. The role of selected metabotropic glutamate receptors in the mechanism of rapid antidepressant effect of RS-ketamine and...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

  12. Interdisciplinary approach to the role of the GABA-ergic and glutamatergic neurotransmission in the effects of mephedron...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Barbara Izabela Budzyńska

    Uniwersytet Medyczny w Lublinie, Wydział Biomedyczny

  13. Investigation of the mechanisms of the neuroprotective effect of group II metabotropic receptors (mGluR2/3) agonist in a...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: dr Ewelina Małgorzata Bratek

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  14. Role of glutamine synthesis in the initial phase of temporal lobe epilepsy in the juvenile rat lithium-pilocarpine model...

    Call: OPUS 12 , Panel: NZ4

    Principal investigator: prof. Jan Albrecht

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  15. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr hab. Magdalena Jolanta Sowa-Kućma

    Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

  16. Pharmacological properties and neurotoxicity of novel NBOMe derivatives

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

  17. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Karolina Sylwia Podkowa

    Instytut Farmakologii PAN

  18. Effects of maternal high-fat or high-sugar diet on the impaired NMDA receptor composition and regulation in offspring in...

    Call: SONATA 10 , Panel: NZ7

    Principal investigator: dr hab. Lucyna Pomierny-Chamioło

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  19. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

  20. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  21. Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  22. Study of SNAP-25 protein expression, NMR metabolomic analysis and behavioral characteristics in animal models of infanti...

    Call: OPUS 8 , Panel: NZ4

    Principal investigator: prof. Jerzy Wiesław Łazarewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  23. Participation of transient receptor potential (TRP) channels premeable for calcium ions in memory formation and retrieva...

    Call: OPUS 8 , Panel: NZ4

    Principal investigator: dr hab. Elżbieta Jolanta Salińska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  24. New selective antagonists of ionotropic glutamate non-NMDA receptors

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr Ewa Monika Szymańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  25. The mechanism of neurotoxic action of benzophenone-3

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Bogusława Budziszewska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  26. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

  27. Searching for molecular basis of addiction-prone phenotype - a role of astrocyte biomarkers (xc-, EAAT2) and metabotropi...

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: Ewa Magdalena Niedzielska-Andres

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  28. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: dr hab. Jadwiga Wardas

    Instytut Farmakologii PAN

  29. New 1,3,4-thiadiazole derivatives as inhibitors of critical steps of the glutamine-glutamate cycle in glioblastoma cells...

    Call: SONATA 6 , Panel: NZ7

    Principal investigator: dr hab. Monika Paulina Szeliga

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  30. Contribution of the glutamate-mediated transmission changes in pedunculopontine tegmental nucleus and nucleus accumbens ...

    Call: PRELUDIUM 5 , Panel: NZ4

    Principal investigator: Karolina Plucińska

    Uniwersytet Gdański, Wydział Biologii

  31. Role of astrocytic NMDA receptors in ammonia-induced brain edema associated with hepatic encephalopathy.

    Call: HARMONIA 4 , Panel: NZ3

    Principal investigator: prof. Jan Albrecht

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  32. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Call: MAESTRO 3 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

  33. The role of the mGlu5-D2 heterodimeric receptor complexes in the extinction of drug seeking behavior associated with dep...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Małgorzata Frankowska

    Instytut Farmakologii PAN, Instytut Farmakologii Polskiej Akademii Nauk